Corrigendum to ‘MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular carcinoma’ [Digestive and Liver Disease Volume 55, Issue 2, February 2023, Pages 283-290]

The authors would like to highlight the following corrections to the published article:•In section 3.3 within the results, it currently states miRNA-142, however this should be corrected to miRNA-124.•In the Acknowledgements the following text should appear: The authors would like to thank Dr. Abdel-Naser Abdel-Atty Gadallah, Internal Medicine Department, Faculty of Medicine, Menoufia University for his help in data collection. The authors would like to apologise for any inconvenience. MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular carcinomaDigestive and Liver DiseaseVol. 55Issue 2PreviewNumerous microRNAs (miRNAs) have been observed to be abnormally expressed in cancer. Therefore, miRNA signatures could be potential noninvasive diagnostic and prognostic biomarkers for hepatocellular carcinoma (HCC). Full-Text PDF